This independent CME/CE activity is supported by an educational grant from Intercept Pharmaceuticals, Inc.



AGA

Chair
faculty image
Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG, FASGE
  • Director
  • Liver Care Network and Organ Care Research
  • Swedish Medical Center
  • Seattle, Washington

  • Date:
    Sunday, October 16, 2016
    Time:
    5:30 AM 
    Registration/Breakfast 

     
    6:00 AM 
    Satellite Symposium 
    Location:
    The Venetian
    3355 South Las Vegas Blvd.
    Venetian Ballrooms G-H
    Las Vegas, NV

    LIVE BREAKFAST SYMPOSIUM--REGISTER NOW!

    Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic, immune-mediated cholangitis with bile duct loss and subsequent cholestasis. The subsequent liver damage results in inflammation and fibrosis with potential progression to cirrhosis and liver cancer.

    Profiling PBC Patients: A Sea-Change in Management offers a compelling, practical, and thorough discussion of the most up-to-date current and emerging management strategies, allowing learners to obtain concise guidance and insights from top clinical specialists.

    This event is neither sponsored by nor endorsed by ACG.
    AGENDA
    6:00-6:05 am
    Introduction
    Kris V. Kowdley, MD
    6:05-6:25 am
    PBC: Patient Profiling and Diagnosis
    David E. Bernstein, MD
    6:25-6:45 am
    Targeted Interventions and Assessment of Treatment Response
    Paul Kwo, MD
    6:45-7:05 am
    Practical Approaches to the Treatment and Management of PBC
    Kris V. Kowdley, MD
    7:05-7:25 am
    Panel: Insights Into Patient Management (Q&A)
    Faculty Panel
    7:25-7:30 am
    Concluding Remarks
    Kris V. Kowdley, MD
    CME/CE Information

    Estimated time for completion of this activity:

    CME: 1.5 hours
    CNE:  1.5 hours
    CPE:  1.5 hours

    Target Audience

    This CME/CE activity is designed for hepatologists, gastroenterologists, infectious disease specialists, primary care providers, nurses, physician assistants, and pharmacists who are involved in the screening and treatment of patients with or at risk for primary biliary cholangitis (PBC).

    Activity Goal

    The goal of this activity is to examine and formulate strategies for the diagnosis, treatment, and management of PBC patients that result in improved patient outcomes.

    Learning Objective(s)

    • Describe PBC, assess the importance of early diagnosis and recent advances in our understanding of pathophysiologic mechanisms that may serve as targets for therapy.
    • Analyze criteria for assessing treatment response in PBC and formulate therapeutic treatment interventions to improve patient outcomes.


    CME Information: Physicians


    Statement of Accreditation

    The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Credit Designation

    The AGA Institute designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    CE Information: Nurses

    Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Upon completion of this course, participants will be awarded 1.50 nursing contact hour(s).

    DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, or PIK endorsement of any commercial product or service.

    CE Information: Pharmacists

    Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

    This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This satellite symposium is worth up to 1.5 contact hour(s) (0.15 CEU). The ACPE Universal Activity Number assigned to this Application-type activity is 0052-0000-16-186-L01-P.

    Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

    CME/CE Instructions


    To obtain credit for the live meeting:

    1. Sign in at the registration desk.
    2. Attend the live satellite symposium.
    3. Complete the evaluation form.
    4. Submit it to the event representative as you exit.
    5. Your certificate will be emailed to you within 4 weeks of the activity date.

    There is no fee for this activity.

    CONTRACT FOR MUTUAL RESPONSIBILITY IN CME/CE

    Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

    For more information on the contract, click here.

    Disclosure Information

    In accordance with the ACCME Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

    Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG, FASGE has received honoraria from Intercept Pharmaceuticals, Inc; has received consulting fees from Intercept Pharmaceuticals, Inc.; and has conducted contracted research for Intercept Pharmaceuticals Inc., and Novartis Pharmaceuticals Corporation.

    David Bernstein, MD, FAASLD, FACG, FACP, AGAF has received consulting fees from Gilead Sciences, Inc., and Intercept Pharmaceuticals, Inc; and has conducted contracted research for Gilead Sciences, Inc. and Intercept Pharmaceuticals, Inc.

    Paul Y. Kwo, MD has received consulting fees from Abbott, AbbVie Inc., Alnylam Pharmaceuticals, Inc., Bristol-Myers Squibb Company, CVS, Gilead Sciences, Inc., Innovio Pharmaceuticals, and Quest Diagnostics; and has conducted contracted research for AbbVie Inc., Bristol-Myers Squibb Company, Conatus Pharmaceuticals, Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc, and Merck Sharpe & Dohme Corporation.

    Peer Reviewer has disclosed no relevant relationships.

    Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no relevant relationships to disclose.
    Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no relevant relationships to disclose.

    Projects In Knowledge's staff members have disclosed no relevant relationships.

    Nancy J. Nordenson, MT (ASCP), MFA (medical writer) has disclosed no relevant relationships.

    Planning Committee
    David Bernstein, MD, FAASLD, FACG, FACP, AGAF has received consulting fees from Gilead Sciences, Inc., and Intercept Pharmaceuticals, Inc; and has conducted contracted research for Gilead Sciences, Inc. and Intercept Pharmaceuticals, Inc.
    Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG, FASGE has received honoraria from Intercept Pharmaceuticals, Inc; has received consulting fees from Intercept Pharmaceuticals, Inc.; and has conducted contracted research for Intercept Pharmaceuticals Inc., and Novartis Pharmaceuticals Corporation.
    Paul Y. Kwo, MD has received consulting fees from Abbott, AbbVie Inc., Alnylam Pharmaceuticals, Inc., Bristol-Myers Squibb Company, CVS, Gilead Sciences, Inc., Innovio Pharmaceuticals, and Quest Diagnostics; and has conducted contracted research for AbbVie Inc., Bristol-Myers Squibb Company, Conatus Pharmaceuticals, Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc, and Merck Sharpe & Dohme Corporation.

    Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

    The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

    This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

    This independent CME/CE activity is supported by an educational grant from Intercept Pharmaceuticals, Inc.

    Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.


    2297 1